Use of Sesbania grandiflora extract for alleviating skin redness caused by dry skin inflammation

Through the water extraction and filtration and concentration technology of Dahuatian Jing extract, a composition that increases keratin, ceramide and hyaluronic acid was prepared, which solved the problem of skin barrier weakening and redness, achieved significant improvement in skin health, and was a natural plant product. Provides a basis for scientific verification.

CN115721585BActive Publication Date: 2024-12-03BIOFUNCTION SHANGHAI BIOTECH GRP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202210913607.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2021-08-02
Filing Date
2022-07-29
Publication Date
2024-12-03
Estimated Expiration
2042-07-29

AI Technical Summary

Technical Problem

The prior art is difficult to effectively utilize Dahuatian Jing extract to strengthen the skin barrier or slow down the skin redness, especially in natural plant products, which lacks a scientific verification basis.

Method used

By extracting substances from the syrup, a composition that strengthens the skin barrier or slows down the redness of the skin is prepared, which increases the production of keratin, ceramide and hyaluronic acid, and a water extraction method combined with filtration and concentration steps are used to prepare suitable foods. , cosmetics or skin care products compositions.

Benefits of technology

It has achieved the strengthening of the skin barrier and slowing down the skin redness, improved the production of keratin, ceramide and hyaluronic acid, significantly improved the skin's health, and provided a scientifically verified foundation for the development of natural plant products.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115721585B_ABST
    Figure CN115721585B_ABST
Patent Text Reader

Abstract

The present invention discloses a use of a Sesbania grandiflora extract. The Sesbania grandiflora extract can be used to prepare a composition for strengthening the skin barrier. In addition, the Sesbania grandiflora extract can also be used to prepare a composition for reducing skin redness.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a sesbania grandiflora extract, and in particular to a use of the sesbania grandiflora extract in preparing a composition for strengthening skin barrier or alleviating skin redness. Background Art

[0002] Since the rise of the concept of organic and natural diets, biotech companies and food companies have actively invested in the research and development of natural plant-related products. In order to provide a scientific basis for the health benefits of plant-related products, the analysis of plant active ingredients and efficacy evaluation have become key projects in product development.

[0003] Sesbania grandiflora, also known as wood sesbania or white butterfly, is a species of the genus Sesbania in the Fabaceae family. Its flowering and fruiting period is from September to April of the following year. The origin of Sesbania grandiflora is unclear. Some say it is native to the West Indies and Florida, USA, while others say it is distributed in tropical Asia and Australia. It is widely distributed from northwest Asia to the Pacific Islands to Africa. Sesbania grandiflora is believed to relieve the symptoms of some diseases, including inflammation, colitis, diarrhea, dysentery, leprosy, gout, rheumatism, jaundice, bronchitis, convulsions and anxiety. It is used as an anti-tumor agent, anthelmintic and laxative in the Ayurvedic and Siddha systems of traditional Indian medicine. Summary of the invention

[0004] The present invention provides the use of a sesbania grandiflora extract for strengthening skin barrier and alleviating skin redness.

[0005] In some embodiments, a Sesbania grandiflora extract is used for preparing a composition for strengthening the skin barrier.

[0006] In some embodiments, Sesbania grandiflora extract is used to increase keratin.

[0007] In some embodiments, Sesbania grandiflora extract is used to increase ceramides.

[0008] In some embodiments, Sesbania grandiflora extract is used to increase hyaluronic acid.

[0009] In some embodiments, a Sesbania grandiflora extract is used for preparing a composition for reducing skin redness.

[0010] In some embodiments, the Sesbania grandiflora extract is used to reduce skin redness caused by skin inflammation.

[0011] In some embodiments, the Sesbania grandiflora extract is obtained by extracting Sesbania grandiflora with water.

[0012] In some embodiments, the weight ratio of water to Sesbania grandiflora is 1-5:1-3.

[0013] In some embodiments, the content of the Sesbania grandiflora extract in the composition is 1 wt %.

[0014] In some embodiments, the composition is a food composition, a cosmetic composition, or a skin care composition.

[0015] In summary, the Sesbania grandiflora extract of any embodiment can be used to prepare a composition for strengthening the skin barrier or alleviating skin redness, so as to be administered to an individual to strengthen the skin barrier of the individual or alleviating skin redness of the individual. BRIEF DESCRIPTION OF THE DRAWINGS

[0016] Figure 1 This is a cell experiment result chart showing relative gene expression levels.

[0017] Figure 2 This is a human experiment analysis chart showing the relative skin redness levels of the experimental group and the control group at week 0 and week 4. DETAILED DESCRIPTION

[0018] The following describes some specific implementations of the present invention. Without departing from the spirit of the present invention, the present invention can be implemented in a variety of different forms, and the scope of protection should not be limited to the conditions specifically stated in the specification.

[0019] In some embodiments, the Sesbania grandiflora extract is obtained by subjecting Sesbania grandiflora to an extraction process.

[0020] In some embodiments, in the extraction process, the Sesbania grandiflora used may be a plant, root, stem, leaf, or flower of Sesbania grandiflora. In some embodiments, the Sesbania grandiflora to be extracted is the whole white flower of Sesbania grandiflora.

[0021] In some embodiments, in the extraction process, the Sesbania grandiflora to be extracted may be raw material (i.e., whole flower), or may be separated into fragments, granules, or powders after physical pretreatment. The physical pretreatment may include at least one of the following: coarse crushing, chopping, shearing, pounding, and grinding.

[0022] In some embodiments, in the extraction process, the Sesbania grandiflora to be extracted may be freshly harvested, dried or frozen Sesbania grandiflora. In some embodiments, the Sesbania grandiflora to be extracted is a dried flower (whole white flower).

[0023] In some embodiments, during the extraction process, the sesbania grandiflora may be first crushed and sieved through a sieve with 8, 10 or 12 meshes, and then the crushed sesbania grandiflora obtained by sieving is used for extraction. For example, the sesbania grandiflora may be crushed by a crusher and then sieved through a sieve with 12 meshes.

[0024] In some embodiments, in the extraction process, the sesbania grandiflora is extracted with water at 85±5° C. for 75 to 100 minutes to obtain a first extract. For example, the sesbania grandiflora can be soaked in 85±5° C. water for 90 minutes to dissolve the active ingredients in the sesbania grandiflora into the water to obtain the first extract, thereby further improving the extraction efficiency and completely retaining the active ingredients in the extract.

[0025] In some embodiments, during the extraction process, the weight ratio of water to Sesbania grandiflora is 1-5:1-3. For example, the weight ratio of water to Sesbania grandiflora is 3:1, so as to further improve the extraction efficiency.

[0026] In some embodiments, during the extraction process, the first extract can be further filtered to remove solids such as Sesbania grandiflora extracted with water to obtain a filtrate. For example, the first extract can be filtered through a 400-mesh filter to remove solids, and the filtrate can be collected.

[0027] In some embodiments, during the extraction process, the filtrate may be further concentrated to obtain a concentrated solution. In some embodiments, the filtrate may be concentrated under reduced pressure at 40°C-55°C to obtain a concentrated solution. For example, the filtrate may be concentrated under reduced pressure at 60°C±5°C. In some embodiments, the duration of concentration may be determined by the Brix value (Degrees Brix; °Bx) of the concentrated solution, but is not limited thereto. Continuing with the previous example, the Brix value of the obtained concentrated solution is 10±0.5. In other words, the filtrate may be concentrated under reduced pressure at 60°C±5°C until the filtrate after reduced pressure concentration has 10±0.5°Bx, and the filtrate after reduced pressure concentration at this time is the concentrated solution.

[0028] In some embodiments, during the extraction process, the concentrate may be further filtered to obtain a concentrated filtrate.

[0029] It should be understood that the first extract, filtrate, concentrated solution or concentrated filtrate obtained from the extraction process can be used as the Sesbania grandiflora extract according to actual needs.

[0030] In some embodiments, the aforementioned Sesbania grandiflora extract has the ability to strengthen the skin barrier. In other words, when the Sesbania grandiflora extract is administered to an individual, it can strengthen the skin barrier of the individual. Therefore, the Sesbania grandiflora extract is suitable for preparing a composition for strengthening the skin barrier.

[0031] In some embodiments, the Sesbania grandiflora extract has the ability to increase keratin, increase ceramide, increase hyaluronic acid, or any combination thereof.

[0032] In other embodiments, the aforementioned Sesbania grandiflora extract has the ability to reduce skin redness. In other words, when the Sesbania grandiflora extract is administered to an individual, it can reduce the redness of the individual's skin. Therefore, the Sesbania grandiflora extract is suitable for preparing a composition for reducing skin redness.

[0033] In some embodiments, the Sesbania grandiflora extract is used to reduce skin redness caused by skin inflammation.

[0034] In some embodiments, in the aforementioned composition, the content of the Sesbania grandiflora extract is 1 wt % (weight percentage).

[0035] In some embodiments, the prepared composition may be a pharmaceutical composition, a food composition, a cosmetic composition, or a skin care product composition.

[0036] In some embodiments, when the aforementioned composition is a pharmaceutical composition, the pharmaceutical composition comprises an effective amount of a Sesbania grandiflora extract, wherein the pharmaceutical composition can be manufactured into a dosage form suitable for enteral, parenteral, oral, or topical administration using techniques well known to those skilled in the art.

[0037] In some embodiments, the enterally or orally administrable dosage form may be, but is not limited to, tablets, troches, lozenges, pills, capsules, dispersible powders or granules, solutions, suspensions, emulsions, syrups, elixirs, slurries, or the like.

[0038] In some embodiments, the parenteral or topical dosage form may be, but is not limited to, an injection (eg, a sterile aqueous solution or dispersion), a sterile powder, an external preparation, or the like.

[0039] In some embodiments, the injection may be administered by, but is not limited to, intraperitoneal injection, subcutaneous injection, intraepidermal injection, intradermal injection, intramuscular injection, intravenous injection, or intralesional injection.

[0040] In some embodiments, the pharmaceutical composition containing an effective amount of Sesbania grandiflora extract may further include a pharmaceutically acceptable carrier widely used in drug manufacturing technology. In some embodiments, the pharmaceutically acceptable carrier may be one or more of the following carriers: solvent, buffer, emulsifier, suspending agent, decomposer, disintegrating agent, dispersing agent, binding agent, excipient, stabilizing agent, chelating agent, diluent, gelling agent, preservative, wetting agent, lubricant, absorption delaying agent, liposome and the like. The type and amount of the selected carrier are within the professional qualities and routine technical scope of those familiar with the technology. The solvent used as the pharmaceutically acceptable carrier may be water, normal saline, phosphate buffered saline (PBS) or an alcohol containing aqueous solution.

[0041] In some embodiments, the pharmaceutical composition containing an effective amount of Sesbania grandiflora extract can be manufactured into an external preparation suitable for topical application to the skin using techniques well known to those skilled in the art. In some embodiments, the external preparation includes, but is not limited to, emulsion, gel, ointment, cream, patch, liniment, powder, aerosol, spray, lotion, serum, paste, foam, drop, suspension, salve, and bandage.

[0042] In some embodiments, when the aforementioned pharmaceutical composition is an external preparation, the pharmaceutical composition can be prepared by mixing an effective amount of the Sesbania grandiflora extract with a base well known to those skilled in the art.

[0043] In some embodiments, the base may include one or more additives selected from the group consisting of water, alcohols, glycols, hydrocarbons (such as petroleum, jelly and white petrolatum), waxes (such as paraffin and yellow wax), preserving agents, antioxidants, surfactants, absorption enhancers, stabilizing agents, gelling agents (such as carbopol® 974P, microcrystalline cellulose and carboxymethylcellulose), active agents, humectants, odor absorbers, fragrances, pH adjusting agents, chelating agents, The additives include emulsifiers, occlusive agents, emollients, thickeners, solubilizing agents, penetration enhancers, anti-irritants, colorants and propellants, etc. The selection and amount of these additives are within the professional qualities and routine skills of those familiar with this technology.

[0044] In some embodiments, when the aforementioned composition is a food composition, the food composition comprises a specific amount of Sesbania grandiflora extract, wherein the food composition can be in the form of powder, granules, solution, colloid or paste.

[0045] In some embodiments, the aforementioned specific content of the Sesbania grandiflora extract may be Sesbania grandiflora juice.

[0046] In some embodiments, the food composition containing the Sesbania grandiflora extract may be a food product or a food additive.

[0047] In some embodiments, the food product containing the Sesbania grandiflora extract may be beverages, fermented foods, bakery products, health foods, or dietary supplements. In some embodiments, the food product containing the Sesbania grandiflora extract may further include an adjuvant. For example, the adjuvant may be maltodextrin, malic acid, sucralose, citric acid, fruit flavors, honey flavors, steviol glycosides, or a combination thereof. The type and amount of the selected carrier are within the scope of professional accomplishment and routine technology of those skilled in the art.

[0048] In some embodiments, the food additive containing the Sesbania grandiflora extract can be a seasoning, a sweetener, a flavoring agent, a pH adjuster, an emulsifier, a colorant, a stabilizer, or the like.

[0049] In some embodiments, when the aforementioned composition is a cosmetic composition or a skin care product composition, in other words, the cosmetic composition or the skin care product composition comprises an effective amount of Sesbania grandiflora extract.

[0050] In some embodiments, the cosmetic composition or skin care composition containing the Sesbania grandiflora extract can be in any of the following forms: lotion, gel, jelly mask, mud mask, emulsion, cream, lipstick, foundation, pressed powder, loose powder, make-up remover oil, make-up remover milk, facial cleanser, shower gel, shampoo, hair conditioner, sunscreen, hand cream, nail polish, perfume, essence and facial mask.

[0051] In some embodiments, the cosmetic composition or skin care product composition containing the Sesbania grandiflora extract may further include an ingredient acceptable to external use, if necessary. In some embodiments, the ingredient acceptable to external use may be, for example, an emulsifier, a penetration enhancer, a softener, a solvent, an excipient, an antioxidant, or a combination thereof.

[0052] Unless otherwise specified in the following examples, the "%" symbol used refers to weight percentage, and the experimental steps were performed at room temperature (25°C) and atmospheric pressure (1 atm).

[0053] Example 1

[0054] A. Raw materials:

[0055] 1. Sesbania Grandiflora, Origin: Taiwan, China.

[0056] 2. Secondary water, also known as RO water (Reverse Osmosis) or double distilled water, hereinafter referred to as "water".

[0057] B. Preparation process:

[0058] 1. The dried flowers (whole white flowers) of Sesbania grandiflora were coarsely pulverized with a blender (model: 12 Speed ​​Blender; brand: Osterizer), and sieved with a 12-mesh sieve to obtain Sesbania grandiflora powder.

[0059] 2. After heating the water to 85±5°C, add the sesbania powder and soak the sesbania powder in the water at 85±5°C for 90 minutes to form a first extract containing solids. Here, the weight ratio of the sesbania powder to water is 1:3.

[0060] 3. Filter the first extract through a 400-mesh filter to remove fine solids to obtain a filtrate.

[0061] 4. The temperature of the concentrator (model: Rotavapor R-100; brand: BUCHI) was set to 60°C±5°C. Under this condition, the filtrate was concentrated under reduced pressure to obtain a concentrate with a Brix of 10±0.5, which was the Sesbania grandiflora extract.

[0062] 5. The prepared Sesbania grandiflora extract was stored in a freezer for subsequent testing.

[0063] Example 2

[0064] A. Materials and Instruments:

[0065] 1. Cell line: Human primary epidermal keratinocytes, purchased from ATCC (American type culture collection), cell number PCS-200-011, hereinafter referred to as HPEK-50 cells.

[0066] 2. Culture medium: Keratinocyte-SFM, purchased from Thermo, product number 17005042.

[0067] 3. RNA extraction reagent kit, purchased from TANBead, product number 04719880122516.

[0068] 4. SuperScript ® III reverse transcriptase, purchased from Invitrogen, product number 18080-044.

[0069] 5. ABI StepOnePlus TMReal-Time PCR system was purchased from Thermo Fisher Scientific.

[0070] 6. KAPA SYBR FAST qPCR Master Mix (2X) Kit, purchased from KAPA Biosystems, product number KK4600.

[0071] B. Test process:

[0072] 1. Plate HPEK-50 cells at 1×10 per well. 5 The cells were seeded at a density of 100 μg / mL in a 6-well culture plate with 2 mL of culture medium per well and cultured at 37°C for 24 h.

[0073] 2. After culture, HPEK-50 cells were divided into two groups: a blank group and an experimental group. The culture medium of the blank group did not contain any extract; the culture medium of the experimental group contained 0.25% (v / v) of the Sesbania grandiflora extract prepared in Example 1. Each group was repeated three times and cultured at 37°C for 24 hours.

[0074] 3. Remove the culture medium from the blank group and experimental group after culture and rinse with PBS.

[0075] 4. After rinsing, the cell membrane of each group of HPEK-50 cells was disrupted with the cell lysis solution of the RNA extraction reagent kit to form a cell solution.

[0076] 5. Use the RNA extraction reagent kit to extract the RNA in the cell solution of each group.

[0077] 6. Take 1000 ng of extracted RNA from each group as template and reverse transcribe the extracted RNA into corresponding cDNA using SuperScript® III reverse transcriptase.

[0078] 7. Use ABI StepOnePlus TMReal-Time PCR system, KAPA SYBR FAST qPCR Master Mix (2X) Kit and the primer combination in Table 1 were used to perform quantitative real-time reverse transcription polymerase chain reaction on cDNA to observe the expression of various target genes and their melting curves in the blank group and experimental group of HPEK-50 cells. The instrument setting conditions for quantitative real-time reverse transcription polymerase chain reaction were 95°C for 20 seconds, 95°C for 3 seconds, 60°C for 30 seconds, and repeated 40 cycles.

[0079] 8. Use 2 -ΔΔCt Method: Determine the relative expression of the target gene. The so-called relative expression is defined as the multiple change of the RNA expression of the target gene in the experimental group or the blank group relative to the RNA expression of the same gene in the blank group. -ΔΔCt Methods The cycle threshold of TBP (TATA-box binding protein) gene was used as the cycle threshold (Ct) of the reference gene for internal control, and the fold change was calculated according to the following formula:

[0080] △Ct = Target gene of Ct experimental group / Target gene of blank group – Ct TBP

[0081] △△Ct = Target gene of △Ct experimental group - Target gene of △Ct blank group

[0082] Fold change = 2 -ΔΔCt平均值

[0083] Table 1

[0084]

[0085] 9. The statistically significant difference between the measurement results of the blank group and the experimental group was obtained by statistical analysis using the student t-test. (In the figure, "*" represents the p-value less than 0.05 compared with the blank group, "**" represents the p-value less than 0.01 compared with the blank group, and "***" represents the p-value less than 0.001 compared with the blank group.)

[0086] C. Test Results:

[0087] See also Figure 1. In the blank group, HPEK-50 cells were not treated with Sesbania grandiflora extract, which means that under normal physiological metabolism, the relative expression of KRT14, GBA and HAS3 genes was 1 times. Compared with the blank group, the relative expression of KRT14 gene in the experimental group was 8 times, an increase of 700%; the relative expression of GBA gene in the experimental group was 12.4 times, an increase of 1140%; the relative expression of HAS3 gene was 1.7 times, an increase of 70%.

[0088] It can be seen that Sesbania grandiflora extract can significantly increase the expression of KRT14 gene. KRT14 gene is responsible for the production of keratin, which together with other keratins forms the cytoskeleton of epithelial cells and plays an important role in the formation of a natural barrier for the skin and can maintain the structure of skin keratinocytes. In other words, Sesbania grandiflora extract can increase the production of keratin, increase keratin, and thus strengthen the skin barrier and / or maintain the structure of skin keratinocytes.

[0089] It can be seen that the extract of Sesbania grandiflora can significantly increase the expression of the GBA gene. The GBA gene is responsible for the production of beta-glucocerebrosidase, which helps break down macromolecules called glucocerebroside into sugar glucose and ceramide. It is present in large quantities in the stratum corneum of the skin. Its activity affects the stability of the skin barrier and prevents the skin from causing inflammatory reactions. In addition, ceramide is a natural lipid in the outermost layer of the skin, accounting for more than 50% of the skin composition, so it plays an important role in fighting external damage. Ceramide can form a protective layer to lock in moisture, fight against the pressure caused by external pollution and environmental factors, and hold skin cells tightly. In addition, ceramide is an anti-aging ingredient that can maintain the perfect structure of healthy skin and reduce the fragility of the skin barrier, which can cause dryness, roughness, wrinkles, sensitivity, redness and peeling. In other words, Sesbania grandiflora extract can increase the production of ceramides, increase ceramides, and thus strengthen the skin barrier, and can also reduce skin inflammation, reduce skin dryness, reduce skin roughness, reduce skin wrinkles, reduce skin sensitivity, reduce skin redness, reduce skin peeling, increase skin moisturization and / or protect against environmental aggressors.

[0090] It can be seen that Sesbania grandiflora extract can significantly increase the expression of the HAS3 gene. The HAS3 gene is responsible for the production of hyaluronan synthase, which is involved in the synthesis of hyaluronic acid. Hyaluronic acid is the main component of the extracellular matrix, which can effectively retain moisture for the skin and reduce or relieve skin inflammation. In other words, Sesbania grandiflora extract can increase the production of hyaluronic acid, increase hyaluronic acid, and thus increase skin moisturizing, reduce or relieve skin inflammation and / or strengthen the skin barrier.

[0091] Example 3

[0092] A. Test process:

[0093] 8 adult subjects with dry and dull skin were asked to apply a placebo and a sesbania grandiflora essence (containing 1% of the sesbania grandiflora extract prepared in Example 1) on the left and right cheeks once a day in the morning and evening for 4 consecutive weeks (i.e., 28 days). The cheek on which the placebo was applied was the control group, and the cheek on which the sesbania grandiflora essence was applied was the experimental group.

[0094] The placebo contained 93.4% water, 0.6% cinnamaldehyde, 0.6% hexanediol, 5% 1,3-butylene glycol, 0.2% trisaccharide gum, 0.1% thickener U21 and 0.1% triethanolamine.

[0095] The sesbania grandiflora essence contains 92.4% water, 0.6% cinnamaldehyde, 0.6% hexanediol, 5% 1,3-butylene glycol, 0.2% trisaccharide gum, 0.1% thickener U21, 0.1% triethanolamine and 1% of the sesbania grandiflora extract prepared in Example 1.

[0096] The subjects underwent skin testing before starting to use (face cleansed, week 0) and after 28 days of use (face cleansed, week 4). Skin testing uses corresponding instruments and measurement methods based on different test items, records facial skin values, and takes photos before and after use. (When testing before and after taking, the temperature and humidity of the test area where the subjects are located are consistent to reduce the impact of external factors such as temperature and humidity on the skin).

[0097] The skin will be tested for the following items:

[0098] Skin redness

[0099] The VISIA Complexion Analysis System purchased from Canfield Scientific, USA, was used to test the facial skin of the same subject before using the Sesbania flower essence (experimental group) and placebo (control group) on the left and right cheeks, and 28 days after using the Sesbania flower essence (experimental group) and placebo (control group) on the left and right cheeks. This detector uses RBX polarized light technology to photograph the facial skin, detect blood vessels or hemoglobin in the deep layer of the skin and obtain a value that can represent the redness of the skin.

[0100] B. Test Results:

[0101] The test results of the subjects' "skin redness" are shown in Figure 2 . The average skin redness of the 8 subjects detected by the VISIA advanced digital skin quality detector before using the Sesbania grandiflora essence and placebo on the left and right cheeks (week 0) was considered 100%. After 4 weeks of continuous use, the average skin redness of the subjects using the Sesbania grandiflora essence (experimental group) was 88.1%, while the average skin redness of the subjects using the placebo (control group) was 96.8%. In other words, compared with before using the Sesbania grandiflora essence (week 0), the continuous use of the essence containing 1% Sesbania grandiflora extract for 4 weeks can reduce the redness of the skin of these subjects by 11.9%. Moreover, compared with the continuous use of the placebo for 4 weeks, the continuous use of the essence containing 1% Sesbania grandiflora extract for 4 weeks can reduce the redness of the skin of these subjects by 8.7%. It can be seen that the Sesbania grandiflora extract can indeed reduce the redness of the skin and improve the skin condition of the subjects, that is, the Sesbania grandiflora extract has the effect of reducing skin redness.

[0102] In summary, the Sesbania grandiflora extract of any embodiment can be used to prepare a composition for strengthening the skin barrier or slowing down the redness of the skin. In other words, the aforementioned composition has the function of strengthening the skin barrier or slowing down the redness of the skin. In some embodiments, the composition prepared from the Sesbania grandiflora extract also has one or more of the following functions: increasing keratin, increasing keratin production, increasing ceramide, increasing ceramide production, increasing hyaluronic acid, increasing hyaluronic acid production and / or slowing down the redness of the skin.

[0103] Of course, the present invention may have many other embodiments. Without departing from the spirit and essence of the present invention, technicians familiar with the field may make various corresponding changes and deformations based on the present invention, but these corresponding changes and deformations should all fall within the scope of protection of the claims of the present invention.

Claims

1. A use of a sesbania grandiflora extract for preparing a composition for alleviating skin redness caused by dry skin inflammation, wherein the sesbania grandiflora extract is obtained by extracting the sesbania grandiflora with water at 85±5°C for 75 to 100 minutes, and the weight ratio of the water to the sesbania grandiflora is 1-5:1-3.

2. The use according to claim 1, characterized in that The Sesbania grandiflora extract is used to increase ceramide.

3. The use according to claim 1, characterized in that The sesbania grandiflora extract is used to increase hyaluronic acid.

4. The use according to any one of claims 1 to 3, characterized in that The content of the Sesbania grandiflora extract in the composition is 1 wt %.

5. The use according to any one of claims 1 to 3, characterized in that The composition is a food composition or a cosmetic composition.